Endovascular Today13d
Avicenna.AI’s Cina-iPE and Cina-ASPECTS Tools Integrated Into Viz.ai One Platform
Viz.ai and Avicenna.AI recently announced that Viz.ai is integrating Avicenna.AI’s Cina-iPE and Cina-ASPECTS tools ...
Endovascular Today13d
Dornier MedTech GmbH
Drug Delivery From ATK to BTK: What Is on the Horizon? With moderator Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed(ClinEpi), and panelists Marianne Brodmann, MD; Osamu ...
Endovascular Today16d
Merit Medical’s Wrapsody Receives FDA Approval
December 20, 2024—Merit Medical Systems, Inc. announced that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the FDA. The company stated that it can begin ...
Endovascular Today16d
Humacyte’s Symvess ATEV Approved by FDA for Treatment of Extremity Vascular Trauma
December 19, 2024—Humacyte, Inc. announced that the FDA has granted full approval for the company’s Symvess—acellular tissue engineered vessel-tyod (ATEV)—for use in adults as a vascular conduit for ...
Endovascular Today17d
Case Report: Removal of Thrombus in Brachial and Ulnar Arteries Via Combined Radial and Femoral Access
Patient Presentation A male in his early 70s with a history of diabetes mellitus, hypertension, hyperlipidemia, and COVID-19 ...
Endovascular Today17d
Case Report: Successful First Case With the Pounce™ Thrombectomy System to Remove Popliteal and Proximal Tibial Thrombi
Patient Presentation A man in his late 50s presented to the emergency department with 4 weeks of acute-onset, severely ...
Endovascular Today17d
Biotronik’s BIO-OSCAR FIRST Trial Begins Enrollment
Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the ...
Endovascular Today17d
Contego’s Neuroguard IEP System Used in First Commercial Procedures
December 19, 2024—Contego Medical announced the first commercial procedures were performed with the company’s Neuroguard IEP system. According to Contego, Neuroguard IEP is a three-in-one device ...
Endovascular Today19d
Flow Medical Secures Seed Funding for Pulmonary Embolism Therapy
December 17, 2024—Flow Medical announced the closing of a $5 million seed funding round that will allow the company to accelerate the development and launch of its device for the treatment of ...
Endovascular Today20d
Fluid Biomed Closes Financing for Studies of ReSolv Stent in Brain Aneurysms
December 16, 2024—Fluid Biomed Inc. announced it closed a $27 million Series A equity financing round. The funds will be used to advance clinical investigations of the company’s bioabsorbable ...
Endovascular Today20d
FastWave Raises Funds to Accelerate Development of IVL Systems to Treat Cardiovascular Calcium
December 16, 2024—FastWave Medical, a clinical-stage medical device company, announced the close of a $19 million funding round earlier this year, increasing the total capital invested into the ...